Hirschsprung Disease – A Complete Patient Guide
Overview
Hirschsprung disease (HD) is a congenital (present at birth) disorder of the large intestine (colon) in which nerve cells, called ganglion cells, are missing from a segment of the bowel. Without these cells, the affected segment cannot relax, leading to a functional blockage that prevents normal stool passage.
- Who it affects: Although it can occur in both sexes, it is about 4‑5 times more common in males. The condition is usually diagnosed in newborns or infants, but milder forms may not be discovered until childhood or even adulthood.
- Prevalence: HD occurs in approximately 1 in 5,000 live births worldwide. In the United States, that translates to roughly 6,000–7,000 new cases each year.
- Geographic variation: The incidence is fairly consistent across ethnic groups, though slightly higher rates have been reported in Asian populations.
Symptoms
Symptoms vary depending on the length of the colon that lacks nerve cells (short‑segment vs. long‑segment disease) and the age of presentation.
Neonatal (first days of life)
- Failure to pass meconium: Most infants with HD do not pass their first stool within the first 48 hours after birth.
- Abdominal distension: The belly may look swollen or feel firm.
- Vomiting: May be non‑bloody initially, progressing to green (bilious) vomiting if obstruction worsens.
- Feeding difficulties: Poor weight gain and irritability.
Infants & toddlers (1 month‑3 years)
- Chronic constipation or difficulty passing stools.
- Large, hard stools that may cause pain or crying during bowel movements.
- “Enterocolitis” – a potentially serious infection of the colon that presents with fever, explosive watery diarrhea, and a foul‑smelling stool.
- Failure to thrive (weight/height below the 5th percentile).
Older children & adults
- Long‑standing constipation that requires laxatives or enemas.
- Abdominal pain or cramping after meals.
- Occasional episodes of severe abdominal bloating.
- In rare adult‑onset cases, megacolon (massive dilation of the colon) may develop.
Causes and Risk Factors
Genetic basis
HD is primarily caused by mutations that affect the development of the enteric nervous system. The most common genes involved are:
- RET proto‑oncogene – mutations account for up to 50 % of familial cases.
- EDNRB, EDN3, GDNF, SOX10 – less common but implicated in syndromic forms.
Approximately 20 % of cases have a family history, and the disease follows an autosomal dominant pattern with variable penetrance, meaning a parent can carry a mutation without showing symptoms.
Associated conditions
- Down syndrome (Trisomy 21): Up to 2 % of children with Down syndrome have HD.
- Waardenburg-Shah syndrome: Characterized by pigmentary abnormalities and hearing loss.
- Congenital heart defects: Slightly increased co‑occurrence.
Risk factors
- Male sex (especially for short‑segment disease).
- Positive family history or known pathogenic gene mutation.
- Having Down syndrome or other chromosomal abnormalities.
Diagnosis
Diagnosing HD requires a combination of clinical suspicion, imaging, and biopsy. The gold‑standard test is a full‑thickness rectal biopsy.
Initial evaluation
- Physical exam: Abdominal distension, palpable stool, and a “squirt” of stool after a digital rectal exam (the “squirt sign”) suggests obstruction.
- History: Timing of first meconium passage, constipation pattern, family history.
Imaging studies
- Contrast enema (barium or water‑soluble): Shows a narrowed distal segment (the aganglionic zone) with a dilated proximal colon (“transition zone”).
- Abdominal X‑ray: May reveal large amounts of stool or air‑fluid levels indicating blockage.
- Anorectal manometry: Detects the absence of the normal “relaxation reflex” of the internal anal sphincter.
Biopsy – definitive test
- Sucrase‑enzyme stained rectal suction biopsy: Small tissue sample examined for the presence or absence of ganglion cells.
- Full‑thickness biopsy: Reserved for ambiguous cases; provides a larger specimen for histology.
Genetic testing
If there is a family history or associated syndromes, testing for RET and other HD‑related genes can guide counseling and future family planning.
Treatment Options
All patients eventually need surgical correction; medical therapy is limited to supportive care before surgery or for postoperative complications.
Pre‑operative management
- Stool softeners & laxatives: Polyethylene glycol (PEG) solutions are commonly used to keep the colon decompressed.
- Rectal irrigations: Daily enemas may be required to prevent stool buildup.
- Enterocolitis treatment: Broad‑spectrum antibiotics (e.g., ampicillin + gentamicin) and IV fluids. Prompt treatment is critical.
Surgical procedures
- Pull‑through surgery (most common): The aganglionic segment is removed, and the healthy colon is pulled through and attached to the anus. Techniques include:
- Transanal Endorectal Pull‑Through (TERPT) – minimal abdominal incision, preferred for short‑segment disease.
- Laparoscopic or open Swenson, Soave, or Duhamel procedures – selected based on disease length and surgeon expertise.
- Stoma creation (temporary): In very ill infants or those with massive colon dilation, a diverting colostomy or ileostomy may be placed first, followed by definitive pull‑through later.
Post‑operative care
- Gradual re‑introduction of oral feeds.
- Continued stool softeners for several weeks.
- Routine follow‑up with pediatric gastroenterology and surgery.
Long‑term medical management
- Laxatives: Low‑dose PEG or lactulose may be needed for ongoing constipation.
- Probiotics: Some clinicians suggest them to reduce the risk of recurrent enterocolitis, though evidence is limited.
- Pelvic floor therapy: Biofeedback can help children who develop functional outlet obstruction after surgery.
Living with Hirschsprung Disease
Daily management tips
- Maintain a high‑fiber diet: Whole grains, fruits, and vegetables help keep stools soft. Aim for age‑appropriate servings (e.g., 25 g fiber/day for a 6‑year‑old).
- Hydration: Encourage 1‑1.5 L of water daily (more if active or hot weather).
- Scheduled toilet times: After meals, allow 10–15 minutes for a bowel attempt; this trains the colon’s “gastrocolic reflex.”
- Medication adherence: Keep a pill or irrigation chart; set alarms if needed.
- School & daycare planning: Provide a written care plan to teachers, including bathroom access and emergency contacts.
- Psychosocial support: Children may feel embarrassed about bathroom issues. Counseling or support groups (e.g., the Hirschsprung’s Disease Society) can improve confidence.
Follow‑up schedule
Typical follow‑up includes:
- First post‑op visit at 2 weeks, then at 3, 6, and 12 months.
- Annual check‑ups thereafter, with additional visits if constipation or enterocolitis symptoms recur.
Prevention
Because HD is congenital, primary prevention is not possible in most cases. However, families can take steps to reduce the risk of complications:
- Genetic counseling: Parents with a known RET mutation or a previous child with HD should consider counseling before future pregnancies.
- Prenatal screening: While routine ultrasound cannot diagnose HD, a detailed fetal survey may detect megacolon in severe cases.
- Early recognition: Prompt presentation to a pediatrician if a newborn does not pass meconium within 48 hours can lead to earlier diagnosis and better outcomes.
Complications
If left untreated or poorly managed, HD can lead to serious health issues:
- Hirschsprung‑associated enterocolitis (HAEC): Occurs in up to 30 % of patients; can cause sepsis, perforation, and death if untreated.
- Acute intestinal obstruction: Severe dilation may require emergency surgery.
- Chronic constipation & fecal impaction: May lead to urinary tract infections or kidney problems due to pressure on the bladder.
- Growth failure: Persistent malnutrition from poor nutrient absorption.
- Reduced bowel function after surgery: Some patients develop “anterior displacement of the anus” or sphincter dysfunction, causing incontinence.
- Psychosocial impact: Anxiety, embarrassment, and school absenteeism related to bowel habits.
When to Seek Emergency Care
- Sudden, severe abdominal swelling or pain.
- Vomiting that is green (bilious) or contains blood.
- Fever ≥ 38 °C (100.4 °F) with watery, foul‑smelling diarrhea – possible enterocolitis.
- Inability to pass gas or stool for more than 24 hours.
- Rapid weight loss or refusal to eat.
- Signs of dehydration (dry mouth, no tears when crying, decreased urine output).
If any of these occur, call 911 or go to the nearest emergency department.
References
- Mayo Clinic. “Hirschsprung disease.” https://www.mayoclinic.org
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Hirschsprung Disease.” https://www.niddk.nih.gov
- American Academy of Pediatrics. “Management of Hirschsprung-associated Enterocolitis.” Pediatrics. 2022;149(2):e2021055213.
- Cleveland Clinic. “Hirschsprung Disease.” https://my.clevelandclinic.org
- World Health Organization. “Rare diseases: key facts.” 2021. https://www.who.int